Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Dual modifications, such as 2,4- and 2,5-sugar modifications, have been employed in the development of siRNA therapeutics to further expand the potential of ribose modifications
Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids
By searching the clinicaltrials.gov database one can see that there are currently no therapeutic agents targeting IGF in phase four clinical trials for endocrine-related cancers
ABC of breast diseases
DOI: 10.1002/14651858.CD010840.pub2
The KLOW stack already contains it, and its anti-inflammatory properties may buffer the local reaction from copper ions
US$ 29.46
US$ 21.83
US$ 23.04
US$ 26.36
